NCT03729674 Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs Status UNKNOWN Phase N/A
NCT03726645 The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients. Status UNKNOWN Phase EARLY_PHASE1
NCT03667625 Stretching in Water and on Land for Patients With Ankylosing Spondylitis Status COMPLETED Phase NA
NCT03636984 Efficacy and Safety Study of Anbainuo in Chinese Patients With RA/AS in the Real World Status UNKNOWN Phase N/A
NCT03557853 Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab Status COMPLETED Phase N/A
NCT03502616 Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) Status COMPLETED Phase PHASE3
NCT03473665 Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis Status TERMINATED Phase PHASE4
NCT03470688 Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents Status UNKNOWN Phase N/A
NCT03457285 Investigating the Use of Salaso to Improve Physiotherapy Management of Ankylosing Spondylitis (AS). Status UNKNOWN Phase NA
NCT03447704 International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT03411798 Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS Status COMPLETED Phase PHASE4
NCT03355573 A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT03350815 Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT03329885 A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis Status TERMINATED Phase PHASE1/PHASE2
NCT03259074 Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) Status COMPLETED Phase PHASE3
NCT03215277 A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT03211559 Clinical Pilates and Aerobic Exercise in Patients With Ankylosing Spondylitis Status COMPLETED Phase NA
NCT03159767 A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis Status COMPLETED Phase NA